Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is used in combination therapy to treat human immunodeficiency virus (HIV) infection by inhibiting viral replication. This category… Read more
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is used in combination therapy to treat human immunodeficiency virus (HIV) infection by inhibiting viral replication. This category offers high-quality reference standards for Delavirdine, including its active pharmaceutical ingredient (API), as well as associated pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous analytical testing, such as impurity profiling and method validation, during the development and quality control of antiretroviral drug substances. By providing accurate benchmarks for identification and quantification, these reference standards ensure compliance with regulatory requirements and support the stability and safety assessment of the drug throughout its manufacturing process.